---
reference_id: "PMID:32805036"
title: "The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment."
authors:
- Haendel MA
- Chute CG
- Bennett TD
- Eichmann DA
- Guinney J
- Kibbe WA
- Payne PRO
- Pfaff ER
- Robinson PN
- Saltz JH
- Spratt H
- Suver C
- Wilbanks J
- Wilcox AB
- Williams AE
- Wu C
- Blacketer C
- Bradford RL
- Cimino JJ
- Clark M
- Colmenares EW
- Francis PA
- Gabriel D
- Graves A
- Hemadri R
- Hong SS
- Hripscak G
- Jiao D
- Klann JG
- Kostka K
- Lee AM
- Lehmann HP
- Lingrey L
- Miller RT
- Morris M
- Murphy SN
- Natarajan K
- Palchuk MB
- Sheikh U
- Solbrig H
- Visweswaran S
- Walden A
- Walters KM
- Weber GM
- Zhang XT
- Zhu RL
- Amor B
- Girvin AT
- Manna A
- Qureshi N
- Kurilla MG
- Michael SG
- Portilla LM
- Rutter JL
- Austin CP
- Gersing KR
- N3C Consortium
journal: J Am Med Inform Assoc
year: '2021'
doi: 10.1093/jamia/ocaa196
content_type: abstract_only
---

# The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment.
**Authors:** Haendel MA, Chute CG, Bennett TD, Eichmann DA, Guinney J, Kibbe WA, Payne PRO, Pfaff ER, Robinson PN, Saltz JH, Spratt H, Suver C, Wilbanks J, Wilcox AB, Williams AE, Wu C, Blacketer C, Bradford RL, Cimino JJ, Clark M, Colmenares EW, Francis PA, Gabriel D, Graves A, Hemadri R, Hong SS, Hripscak G, Jiao D, Klann JG, Kostka K, Lee AM, Lehmann HP, Lingrey L, Miller RT, Morris M, Murphy SN, Natarajan K, Palchuk MB, Sheikh U, Solbrig H, Visweswaran S, Walden A, Walters KM, Weber GM, Zhang XT, Zhu RL, Amor B, Girvin AT, Manna A, Qureshi N, Kurilla MG, Michael SG, Portilla LM, Rutter JL, Austin CP, Gersing KR, N3C Consortium
**Journal:** J Am Med Inform Assoc (2021)
**DOI:** [10.1093/jamia/ocaa196](https://doi.org/10.1093/jamia/ocaa196)

## Content

1. J Am Med Inform Assoc. 2021 Mar 1;28(3):427-443. doi: 10.1093/jamia/ocaa196.

The National COVID Cohort Collaborative (N3C): Rationale, design, 
infrastructure, and deployment.

Haendel MA(1)(2), Chute CG(3), Bennett TD(4), Eichmann DA(5), Guinney J(6), 
Kibbe WA(7), Payne PRO(8), Pfaff ER(9), Robinson PN(10), Saltz JH(11), Spratt 
H(12), Suver C(6), Wilbanks J(6), Wilcox AB(13), Williams AE(14), Wu C(15), 
Blacketer C(16), Bradford RL(9), Cimino JJ(17), Clark M(9), Colmenares EW(18), 
Francis PA(19), Gabriel D(19), Graves A(20), Hemadri R(21), Hong SS(19), 
Hripscak G(22), Jiao D(19), Klann JG(23), Kostka K(24), Lee AM(25), Lehmann 
HP(19), Lingrey L(26), Miller RT(27), Morris M(28), Murphy SN(29), Natarajan 
K(30), Palchuk MB(26), Sheikh U(21), Solbrig H(19), Visweswaran S(28), Walden 
A(1)(6), Walters KM(9), Weber GM(31), Zhang XT(19), Zhu RL(19), Amor B(32), 
Girvin AT(32), Manna A(32), Qureshi N(32), Kurilla MG(33), Michael SG(34), 
Portilla LM(35), Rutter JL(36), Austin CP(34), Gersing KR(21); N3C Consortium.

Collaborators: Haendel MA, Chute CG, Bennett TD, Eichmann DA, Guinney J, Kibbe 
WA, Payne PRO, Pfaff ER, Robinson PN, Saltz JH, Spratt H, Suver C, Wilbanks J, 
Wilcox AB, Williams AE, Wu C, Blacketer C, Bradford RL, Cimino JJ, Clark M, 
Colmenares EW, Francis PA, Gabriel D, Graves A, Hemadri R, Hong SS, Hripscak G, 
Jiao D, Klann JG, Kostka K, Lee AM, Lehmann HP, Lingrey L, Miller RT, Morris M, 
Murphy SN, Natarajan K, Palchuk MB, Sheikh U, Solbrig H, Visweswaran S, Walden 
A, Walters KM, Weber GM, Zhang XT, Zhu RL, Amor B, Girvin AT, Manna A, Qureshi 
N, Kurilla MG, Michael SG, Portilla LM, Rutter JL, Austin CP, Gersing KR, 
Al-Shukri S, Alaoui A, Cook C, Crandall KA, Deacy M, Dietz RR, Dobbins NJ, 
Baghal A, Banning PD, Barbour EM, Becich MJ, Beheshti A, Bernard GR, 
Bhattacharyya S, Bissell MM, Boulware LE, Bozzette S, Brown DE, Buse JB, Bush 
BJ, Callahan TJ, Campion TR, Casiraghi E, Chaudhry AA, Chen G, Chen A, Clifford 
GD, Coffee MP, Conlin T, Elkin PL, Embi PJ, Facelli JC, Fecho K, Feng X, Foraker 
RE, Gal TS, Ge L, Golovko G, Gouripeddi R, Greene CS, Gupta S, Gupta A, Hajagos 
JG, Hanauer DA, Harper JR, Harris NL, Harris PA, Hassan MR, He Y, Hill EL, 
Hoatlin ME, Holmes KL, Hughes L, Jawa RS, Jiang G, Jing X, Joachimiak MP, 
Johnson SG, Kamaleswaran R, Kannampallil TG, Kanter AS, Kavuluru R, Khanipov K, 
Kharrazi H, Kim D, Knosp BM, Krishnan A, Kurc T, Lai AM, Lambert CG, Larionov M, 
Lee SB, Lesh MD, Lichtarge O, Liu J, Liu S, Liu H, Loomba JJ, Mallipattu SK, 
Mamillapalli CK, Mason CE, Mathew JP, McClay JC, McMurry JA, Mehta PP, 
Mendelevitch O, Meystre S, Moffitt RA, Moore JH, Morizono H, Mungall CJ, 
Munoz-Torres MC, Neumann AJ, Ning X, Nyland JE, O'Malley A, O'Neil ST, Obeid JS, 
Ogburn EL, Phuong J, Posada JD, Prasanna P, Prior F, Prosser J, Purnell AL, 
Rahnavard A, Ramadas H, Reese JT, Robinson JL, Rubin DL, Rutherford CD, Sadhu 
EM, Saha A, Saltz MM, Schaffter T, Schleyer TK, Setoguchi S, Shah NH, 
Sharafeldin N, Sholle E, Silverstein JC, Solomonides A, Solway J, Su J, Subbian 
V, Tak HJ, Taylor BW, Thessen AE, Thomas JA, Topaloglu U, Unni DR, Vogelstein 
JT, Volz AM, Williams DA, Wilson KM, Xu CB, Xu H, Yan Y, Zak E, Zhang L, Zhang 
C, Zheng J.

Author information:
(1)Oregon Clinical and Translational Research Institute, Oregon Health and 
Science University, Portland, Oregon, USA.
(2)Translational and Integrative Sciences Center, Department of Molecular 
Toxicology, Oregon State University, Corvallis, Oregon, USA.
(3)Schools of Medicine, Public Health, and Nursing, Johns Hopkins University, 
Baltimore, Maryland, USA.
(4)Section of Informatics and Data Science, Department of Pediatrics, University 
of Colorado School of Medicine, University of Colorado, Aurora, Colorado, USA.
(5)School of Library and Information Science, The University of Iowa, Iowa City, 
Iowa, USA.
(6)Sage Bionetworks, Seattle, Washington, USA.
(7)Duke University, Durham,North Carolina, USA.
(8)Institute for Informatics, Washington University in St. Louis, Saint 
Louis,Missouri, USA.
(9)North Carolina Translational and Clinical Sciences Institute (NC TraCS), 
University of North Carolina at Chapel Hill, Chapel Hill,North Carolina, USA.
(10)Jackson Laboratory, Bar Harbor, Maine, USA.
(11)Department of Biomedical Informatics, Stony Brook University, Stony Brook, 
New York, USA.
(12)University of Texas Medical Branch, Galveston, Texas, USA.
(13)University of Washington, Seattle, Washington, USA.
(14)Tufts Medical Center Clinical and Translational Science Institute, Tufts 
Medical Center, Boston,Massachusetts, USA.
(15)Department of Integrative Structural and Computational Biology, The Scripps 
Research Institute, La Jolla, California, USA.
(16)Janssen Research and Development, LLC, Raritan, New Jersey, USA.
(17)University of Alabama-Birmingham, Birmingham, Alabama, USA.
(18)Department of Pharmaceutical Outcomes and Policy, University of North 
Carolina at Chapel Hill, Chapel Hill,North Carolina, USA.
(19)Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
(20)University of Iowa Institute for Clinical and Translational Science, The 
University of Iowa, Iowa City, Iowa, USA.
(21)National Center for Advancing Translational Science, Bethesda, Maryland, 
USA.
(22)Department of Biomedical Informatics, Columbia University, New York, New 
York, USA.
(23)Harvard Medical School, Boston,Massachusetts, USA.
(24)IQVIA, Durham, North Carolina, USA.
(25)University of North Carolina at Chapel Hill, Chapel Hill,North Carolina, 
USA.
(26)TriNetX, Cambridge,Massachusetts, USA.
(27)Tufts Clinical and Translational Science Institute, Tufts University, 
Boston,Massachusetts, USA.
(28)Department of Biomedical Informatics, University of Pittsburgh, 
Pittsburgh,Pennsylvania, USA.
(29)Mass General Brigham, Boston,Massachusetts, USA.
(30)Irving Medical Center, Columbia University, New York, New York, USA.
(31)Department of Biomedical Informatics, Harvard Medical School, 
Boston,Massachusetts, USA.
(32)Palantir Technologies, Palo Alto, California, USA.
(33)Division of Clinical Innovation, National Center for Advancing Translational 
Science, Bethesda, Maryland, USA.
(34)National Center for Advancing Translational Sciences, National Institutes of 
Health, Bethesda, Maryland, USA.
(35)Office of Strategic Alliances, National Center for Advancing Translational 
Sciences, National Institutes of Health, Bethesda, Maryland, USA.
(36)Office of the Director, National Center for Advancing Translational Science, 
Bethesda, Maryland, USA.

OBJECTIVE: Coronavirus disease 2019 (COVID-19) poses societal challenges that 
require expeditious data and knowledge sharing. Though organizational clinical 
data are abundant, these are largely inaccessible to outside researchers. 
Statistical, machine learning, and causal analyses are most successful with 
large-scale data beyond what is available in any given organization. Here, we 
introduce the National COVID Cohort Collaborative (N3C), an open science 
community focused on analyzing patient-level data from many centers.
MATERIALS AND METHODS: The Clinical and Translational Science Award Program and 
scientific community created N3C to overcome technical, regulatory, policy, and 
governance barriers to sharing and harmonizing individual-level clinical data. 
We developed solutions to extract, aggregate, and harmonize data across 
organizations and data models, and created a secure data enclave to enable 
efficient, transparent, and reproducible collaborative analytics.
RESULTS: Organized in inclusive workstreams, we created legal agreements and 
governance for organizations and researchers; data extraction scripts to 
identify and ingest positive, negative, and possible COVID-19 cases; a data 
quality assurance and harmonization pipeline to create a single harmonized 
dataset; population of the secure data enclave with data, machine learning, and 
statistical analytics tools; dissemination mechanisms; and a synthetic data 
pilot to democratize data access.
CONCLUSIONS: The N3C has demonstrated that a multisite collaborative learning 
health network can overcome barriers to rapidly build a scalable infrastructure 
incorporating multiorganizational clinical data for COVID-19 analytics. We 
expect this effort to save lives by enabling rapid collaboration among 
clinicians, researchers, and data scientists to identify treatments and 
specialized care and thereby reduce the immediate and long-term impacts of 
COVID-19.

Â© The Author(s) 2020. Published by Oxford University Press on behalf of the 
American Medical Informatics Association.

DOI: 10.1093/jamia/ocaa196
PMCID: PMC7454687
PMID: 32805036 [Indexed for MEDLINE]